BioTech

#TradeTalks: How the C-1 Gene Expression Platform Could Make #COVID-19 Treatment more Affordable

Published

Dyadic International CEO Mark Emalfarb joins Jill Malandrino on Nasdaq #TradeTalks to discuss how the C-1 Gene Expression Platform can potentially make #COVID-19 treatment more affordable.

Nasdaq Watch

See what's playing at Nasdaq

Watch Now